SCHEMBL6581776

SCHEMBL6581776

CCCCCCOc1ccc2nc([S+]([O-])CCC)n(-c3ccc(C)cc3)c2c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.39
PDE10A Q9Y233 3/20 0.39
PDE2A O00408 10/20 0.38
TP53 P04637 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
CACNA2D1 P54289 1/20 0.35
FGFR1 P11362 1/20 0.35
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
TLR8 Q9NR97 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6377580 0.90 PDE3B (0.42) CYP1A2PDE10APDE2A
SCHEMBL5420165 0.88 PDE3B (0.44) CYP1A2PDE10APDE2ATP53
SCHEMBL6585534 0.85 PDE10A (0.43) CYP1A2PDE10APDE2ATP53GAA
SCHEMBL6584270 0.81 PDE2A (0.44) CYP1A2PDE10APDE2ATP53GAA
SCHEMBL5424244 0.80 PDE3B (0.45) CYP1A2PDE10APDE2A
SCHEMBL5420162 0.79 PPARG (0.43) PDE2ATP53
SCHEMBL7719001 0.78 CYP1A2 (0.39) CYP1A2PDE10APDE2ATP53GAA
SCHEMBL6618378 0.77 CYP3A4 (0.44) CYP1A2PDE10APDE2ATP53GAA
SCHEMBL6583523 0.77 APLNR (0.47) CYP1A2PDE10APDE2A
SCHEMBL5412722 0.77 PDE3B (0.43) CYP1A2PDE10APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404656-A1 BENZIMIDAZOLE DERIVATIVES FOR TREATING MICROGLIA-ACTIVATION ASSOCIATED DISEASES SUCH AS INFLAMMATORY, ALLERGIC, INFECTIOUS OR AUTOIMMUNE DISEASES SCHERING AKTIENGESELLSCHAFT (DE) 2004-04-07 EP disclosed
WO-2003006438-A1 BENZIMIDAZOLE DERIVATIVES FOR TREATING MICROGLIA-ACTIVATION ASSOCIATED DISEASES SUCH AS INFLAMMATORY, ALLERGIC, INFECTIOUS OR AUTOIMMUNE DISEASES SCHERING AKTIENGESELLSCHAFT (DE) 2003-01-23 WO disclosed